Epstein Secrets

STUART C3070 - STUART ORSHER, M.D. 9 EAST 79TH ST, NEW YORK, NY 10021 Acct 0: CLINICAL REPORT A.Phagocytophila LEG Ab (24) <1:64 8.Henselae IgG Ab (3) 1:64 * < 1:64 titer B.Henvelae ICI Ab (3) <1:20 < 1:20 titer EPSTEIN, JEFFREY DOB: 01/20/1953 Age: 64 Y Sex: M U/FL: Bed: Rm: Patien

ID: Address:9 EAST 71ST STREET, NEw YORK, NY 20021 This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics Nichols Institute Valencia. It has not been cleared or approved by the US Food and Drug Administration. This assay has been validated pursuant to the CLIA regulation

C3070 - STUART ORSHER, III. 9 EAST 79TH ST, NEW YORK, NY 10021 Acct (C3070) P. CLINICAL REPORT A.Phagocytophila LEG Ab (24) <1:64 8.Henselae IgG Ab (3) 1:64 * < 1:64 titer B.Henvelae ICIAb (3) <1:20 < 1:20 titer EPSTEIN, lEFEREY DOB: 01/20/1951 Age: 64 Y Sex: H U/FL: Bed: Rm: Patient

ID: Address:9 EAST 7157 STREET, rev YORK, NY 20021 This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics Nichols Institute Valencia. It has not been cleaned or approved by the US Food and Drug Administration. This assay has been validated pursuant to the CLIA regulation

Ab TYPE 19 (19F) 1.1 LO PNEUMO Ab TYPE 23 (23F) 0.3 LD PRELIM° Ab TYPE 26 (68) 8.9 LO (58) (58) (58) PNEUMO Ab TYPE 68 (9V) 9.5 LO B.Henselae IgG Ab 1:64 • (58) (3) Albumin 4.7 9.8 3.5.5.2 8.6-12.4 g/dL Ing/ill• • 4.5 9.7 08/30/1017 30 - .Calcium -* CARDIOVASCULAR/LIPIDS *-- 224HI <

08/30/2017 '08/30/aiii'l. • titer 1:64 g titer This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics Nichols Institute Valencia. It has not been cleared or approved by the US Food and Drug Administration. This assay has been validated pursuant to the CLIA regulation